Sean Murphy insider trades

Open-market stock purchases and sales by Sean Murphy, Director at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Sep 20, 2016.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -39%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • TLSI TriSalus Life Sciences, Inc: 2 buys, last Jun 12, 2025
  • RDUS Radius Health, Inc: other filings, last Aug 15, 2022
  • PSTX Poseida Therapeutics, Inc: 1 buy, last Jul 14, 2020
  • NOVN Novan, Inc: other filings, last Jun 4, 2018

Get free alerts when Sean Murphy files a new trade →